Fyn tyrosine kinase is a critical regulator of Disabled-1 during brain development

Current Biology

Volumn 13, Issue 1, 2003, Pages 9-17

  Arnaud, Lionel ^a   Ballif, Bryan A ^a   Förster, Eckart ^b   Cooper, Jonathan A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; DAB1 PROTEIN, MOUSE; ENZYME INHIBITOR; FYN PROTEIN, HUMAN; FYN PROTEIN, MOUSE; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; REELIN PROTEIN; SCLEROPROTEIN; SEMINAL PLASMA PROTEIN; SERINE PROTEINASE; TYROSINE; YES1 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BRAIN; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-FYN; PROTO-ONCOGENE PROTEINS C-YES; SEMINAL PLASMA PROTEINS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE;

ANIMALIA; MAMMALIA; VERTEBRATA;

EID: 0037425580     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)01397-0     Document Type: Article

References (51)

1. Rice, D.S., and Curran, T. (2001). Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 24, 1005-1039.
2. Gleeson, J.G., and Walsh, C.A. (2000). Neuronal migration disorders: from genetic diseases to developmental mechanisms. Trends Neurosci. 23, 352-359.
3. D'Arcangelo, G., Miao, G.G., Chen, S.C., Soares, H.D., Morgan, J.I., and Curran, T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723.
4. Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R.E., Richardson, J.A., and Herz, J. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.
5. D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D.S., Sheldon, M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479.
6. Hiesberger, T., Trommsdorff, M., Howell, B.W., Goffinet, A., Mumby, M.C., Cooper, J.A., and Herz, J. (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489.
7. Senzaki, K., Ogawa, M., and Yagi, T. (1999). Proteins of the CNR family are multiple receptors for Reelin. Cell 99, 635-647.
8. Dulabon, L., Olson, E.C., Taglienti, M.G., Eisenhuth, S., McGrath, B., Walsh, C.A., Kreidberg, J.A., and Anton, E.S. (2000). Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron 27, 33-44.
9. Howell, B.W., Herrick, T.M., and Cooper, J.A. (1999). Reelin-induced tyrosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13, 643-648.
10. Howell, B.W., Hawkes, R., Soriano, P. and Cooper, J.A. (1997). Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733-737.
11. Sheldon, M., Rice, D.S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B.W., Cooper, J.A., Goldowitz, D., and Curran, T. (1997). Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730-733.
12. Ware, M.L., Fox, J.W., Gonzalez, J.L., Davis, N.M., Lambert de Rouvroit, C., Russo, C.J., Chua, S.C., Jr., Goffinet, A.M., and Walsh, C.A. (1997). Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron 19, 239-249.
13. Howell, B.W., Herrick, T.M., Hildebrand, J.D., Zhang, Y., and Cooper, J.A. (2000). Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development. Curr. Biol. 10, 877-885.
14. Veillette, A., Bookman, M.A., Horak, E.M., and Bolen, J.B. (1988). The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55, 301-308.
15. Woodside, D.G., Obergfell, A., Leng, L., Wilsbacher, J.L., Miranti, C.K., Brugge, J.S., Shattil, S.J., and Ginsberg, M.H. (2001). Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr. Biol. 11, 1799-1804.
16. Luttrell, L.M., Ferguson, S.S., Daaka, Y., Miller, W.E., Maudsley, S., Della Rocca, G.J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D.K., et al. (1999). Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.
17. Howell, B.W., Gertler, F.B., and Cooper, J.A. (1997). Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J. 16, 121-132.
18. Zhou, S., Carraway, K.L., 3rd, Eck, M.J., Harrison, S.C., Feldman, R.A., Mohammadi, M., Schlessinger, J., Hubbard, S.R., Smith, D.P., Eng, C., et al. (1995). Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373, 536-539.
19. Keshvara, L., Benhayon, D., Magdaleno, S., and Curran, T. (2001). Identification of reelin-induced sites of tyrosyl phosphorylation on disabled 1. J. Biol. Chem. 276, 16008-16014.
20. Gertler, F.B., Bennett, R.L., Clark, M.J., and Hoffmann, F.M. (1989). Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58, 103-113.
21. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
22. Stein, P.L., Lee, H.M., Rich, S., and Soriano, P. (1992). pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70, 741-750.
23. Stein, P.L., Vogel, H., and Soriano, P. (1994). Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8, 1999-2007.
24. Koleske, A.J., Gifford, A.M., Scott, M.L., Nee, M., Bronson, R.T., Miczek, K.A., and Baltimore, D. (1998). Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272.
25. Schwartzberg, P.L., Stall, A.M., Hardin, J.D., Bowdish, K.S., Humaran, T., Boast, S., Harbison, M.L., Robertson, E.J., and Goff, S.P. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175.
26. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
27. Martinez, R., Mathey-Prevot, B., Bernards, A., and Baltimore, D. (1987). Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. Science 237, 411-415.
28. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B.J., and Lydon, N.B. (1996). Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56, 100-104.
29. Hanke, J.H., Gardner, J.P., Dow, R.L., Changelian, P.S., Brissette, W.H., Weringer, E.J., Pollok, B.A., and Connelly, P.A. (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701.
30. Liu, Y., Bishop, A., Witucki, L., Kraybill, B., Shimizu, E., Tsien, J., Ubersax, J., Blethrow, J., Morgan, D.O., and Shokat, K.M. (1999). Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671-678.
31. Kmiecik, T.E., Johnson, P.J., and Shalloway, D. (1988). Regulation by the autophosphorylation site in overexpressed pp60c-src. Mol. Cell. Biol. 8, 4541-4546.
32. Brown, M.T., and Cooper, J.A. (1996). Regulation, substrates and functions of src. Biochim. Biophys. Acta 1287, 121-149.
33. Xu, W., Doshi, A., Lei, M., Eck, M.J., and Harrison, S.C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629-638.
34. Rice, D.S., Sheldon, M., D'Arcangelo, G., Nakajima, K., Goldowitz, D., and Curran, T. (1998). Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development 125, 3719-3729.
35. Bock, H., and Herz, J. (2003). Reelin activates Src family tyrosine kinases in neurons. Curr. Biol. 13, 18-26.
36. Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N.B., Gilliland, D.G., and Druker, B.J. (1997). CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TELPDGFR fusion proteins. Blood 90, 4947-4952.
37. Okuda, K., Weisberg, E., Gilliland, D.G., and Griffin, J.D. (2001). ARG tyrosine kinase activity is inhibited by STI571. Blood 97, 2440-2448.
38. Traxler, P., Bold, G., Frei, J., Lang, M., Lydon, N., Mett, H., Buchdunger, E., Meyer, T., Mueller, M., and Furet, P. (1997). Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J. Med. Chem. 40, 3601-3616.
39. Blake, R.A., Garcia-Paramio, P., Parker, P.J., and Courtneidge, S.A. (1999). Src promotes PKCdelta degradation. Cell Growth Differ. 10, 231-241.
40. Buchdunger, E., Cioffi, C.L., Law, N., Stover, D., Ohno-Jones, S., Druker, B.J., and Lydon, N.B. (2000). Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295, 139-145.
41. Levitzki, A., and Gazit, A. (1995). Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782-1788.
42. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C.H., Kuriyan, J., and Miller, W.T. (1997). Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653.
43. Liu, X., Brodeur, S.R., Gish, G., Songyang, Z., Cantley, L.C., Laudano, A.P., and Pawson, T. (1993). Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene 8, 1119-1126.
44. Gonfloni, S., Weijland, A., Kretzschmar, J., and Superti-Furga, G. (2000). Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src. Nat. Struct. Biol. 7, 281-286.
45. Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
46. Kohmura, N., Senzaki, K., Hamada, S., Kai, N., Yasuda, R., Watanabe, M., Ishii, H., Yasuda, M., Mishina, M., and Yagi, T. (1998). Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron 20, 1137-1151.
47. Umemori, H., Kadowaki, Y., Hirosawa, K., Yoshida, Y., Hironaka, K., Okano, H., and Yamamoto, T. (1999). Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination. J. Neurosci. 19, 1393-1397.
48. Sperber, B.R., Boyle-Walsh, E.A., Engleka, M.J., Gadue, P., Peterson, A.C., Stein, P.L., Scherer, S.S., and McMorris, F.A. (2001). A unique role for Fyn in CNS myelination. J. Neurosci. 21, 2039-2047.
49. Grant, S.G., O'Dell, T.J., Karl, K.A., Stein, P.L., Soriano, P., and Kandel, E.R. (1992). Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258, 1903-1910.
50. Miyakawa, T., Yagi, T., Kitazawa, H., Yasuda, M., Kawai, N., Tsuboi, K., and Niki, H. (1997). Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA- receptor function. Science 278, 698-701.
51. Koshland, D.E., Jr. (1981). Biochemistry of sensing and adaptation in a simple bacterial system. Annu. Rev. Biochem. 50, 765-782.